ArriVent BioPharma (NASDAQ:AVBP) Stock Quotes, Forecast and News Summary

Q: What sector and industry does ArriVent BioPharma (AVBP) operate in?

ArriVent BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ArriVent BioPharma Stock (NASDAQ: AVBP) stock price, news, charts, stock research, profile.

Open	$20.75
Close	$21.14
Volume / Avg.	64.70K / 59.26K
Day Range	20.45 - 21.44
52 Wk Range	14.35 - 25.95
Market Cap	$708.06M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	67
Short Interest	6.71%
Days to Cover	24.84

Recent News

ProfoundBio Discovers The Joys Of Having A Wealthy Owner

Key Takeaways: Cancer treatment maker ProfoundBio announced it will be purchased by Denmark’s Genmab for $1.8 billion The deal is the fourth acquisition of a China-related innovative drugmaker by a foreign company in the last four months By Doug Young

The Bamboo Works

$10M Bet On ArriVent BioPharma? Check Out These 4 Stocks Insiders Are Buying

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About ArriVent BioPharma Inc.

Sector

Health Care

Industry

Biotechnology

ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy ArriVent BioPharma (AVBP) stock?

You can purchase shares of ArriVent BioPharma (NASDAQ:AVBP) through any online brokerage.

View our list of the best stock brokerages

Who are ArriVent BioPharma (AVBP) competitors?

Other companies in ArriVent BioPharma’s space includes: KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC), Larimar Therapeutics (NASDAQ:LRMR), Replimune Group (NASDAQ:REPL) and Sage Therapeutics (NASDAQ:SAGE).

What is the target price for ArriVent BioPharma (AVBP) stock?

There is no analysis for ArriVent BioPharma.

What is the forecast for ArriVent BioPharma (AVBP) stock?

ArriVent BioPharma has a consensus price target of $29.25.

Current stock price for ArriVent BioPharma (AVBP)?

The stock price for ArriVent BioPharma (NASDAQ: AVBP) is $21.14 last updated July 25, 2024 at 4:01 PM EDT.

Does ArriVent BioPharma (AVBP) pay a dividend?

There are no upcoming dividends for ArriVent BioPharma.

When is ArriVent BioPharma (NASDAQ:AVBP) reporting earnings?

ArriVent BioPharma’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Is ArriVent BioPharma (AVBP) going to split?

There is no upcoming split for ArriVent BioPharma.

What sector and industry does ArriVent BioPharma (AVBP) operate in?

ArriVent BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

ArriVent BioPharma

ArriVent BioPharma (AVBP) Forecast